Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertension

British Journal of Nutrition

Volumn 110, Issue 12, 2013, Pages 2234-2241

  Ras, Rouyanne T ^a   Zock, Peter L ^a,b   Zebregs, Yvonne E M P ^a   Johnston, Neil R ^c   Webb, David J ^c   Draijer, Richard ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Blood pressure; Cardiovascular health; Dietary intervention studies; Grape seed extract

Indexed keywords

ENDOTHELIN 1; GRAPE SEED EXTRACT; MEGANATURAL BP; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PLACEBO; POLYPHENOL; RENIN; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLANT EXTRACTS; POLYPHENOLS; PREHYPERTENSION; SEEDS; VITIS;

EID: 84889257101     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451300161X     Document Type: Article

References (47)

1. Kearney PM, Whelton M, Reynolds K, et al. (2005) Global burden of hypertension: Analysis of worldwide data. Lancet 365, 217-223.
2. Lewington S, Clarke R, Qizilbash N, et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-Analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913.
3. Hertog MG, Feskens EJ, Hollman PC, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342, 1007-1011.
4. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 75, 880-886.
5. Knekt P, Jarvinen R, Reunanen A, et al. (1996) Flavonoid intake and coronary mortality in Finland: A cohort study. Br Med J 312, 478-481.
6. Yochum L, Kushi LH, Meyer K, et al. (1999) Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149, 943-949.
7. Xu Y, Simon JE, Welch C, et al. (2011) Survey of polyphenol constituents in grapes and grape-derived products. J Agric Food Chem 59, 10586-10593.
8. Preuss HG, Wallerstedt D, Talpur N, et al. (2000) Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J Med 31, 227-246.
9. Castilla P, Echarri R, Davalos A, et al. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84, 252-262.
10. Clifton PM (2004) Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. J Biomed Biotechnol 2004, 272-278.
11. Stein JH, Keevil JG, Wiebe DA, et al. (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050-1055.
12. Chaves AA, Joshi MS, Coyle CM, et al. (2009) Vasoprotective endothelial effects of a standardized grape product in humans. Vascul Pharmacol 50, 20-26.
13. Hashimoto M, Kim S, Eto M, et al. (2001) Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88, 1457-1460, A9.
14. Barona J, Aristizabal JC, Blesso CN, et al. (2012) Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 142, 1626-1632.
15. Freedman JE, Parker C, Li L, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792-2798.
16. Keevil JG, Osman HE, Reed JD, et al. (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130, 53-56.
17. Shenoy SF, Keen CL, Kalgaonkar S, et al. (2007) Effects of grape seed extract consumption on platelet function in postmenopausal women. Thromb Res 121, 431-432.
18. van Mierlo LA, Zock PL, van der Knaap HC, et al. (2010) Grape polyphenols do not affect vascular function in healthy men. J Nutr 140, 1769-1773.
19. Ward NC, Hodgson JM, Croft KD, et al. (2005) The combination of vitamin C and grape-seed polyphenols increases blood pressure: A randomized, double-blind, placebocontrolled trial. J Hypertens 23, 427-434.
20. Sano A, Uchida R, Saito M, et al. (2007) Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol (Tokyo) 53, 174-182.
21. Park YK, Kim JS & Kang MH (2004) Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: Double-blind, placebo controlled intervention trial. Biofactors 22, 145-147.
22. Sivaprakasapillai B, Edirisinghe I, Randolph J, et al. (2009) Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 58, 1743-1746.
23. Dohadwala MM, Hamburg NM, Holbrook M, et al. (2010) Effects of Concord grape juice on ambulatory blood pressure in prehypertension and stage 1 hypertension. Am J Clin Nutr 92, 1052-1059.
24. Ried K, Sullivan TR, Fakler P, et al. (2012) Effect of cocoa on blood pressure. The Cochrane Database of Systematic Reviews 8, CD008893.
25. Hodgson JM, Puddey IB, Woodman RJ, et al. (2012) Effects of black tea on blood pressure: A randomized controlled trial. Arch Intern Med 172, 186-188.
26. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
27. Shrikhande AJ, Race EJ, Wightman JLD, et al. (2004) Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace. Patent US6544581 B1.
28. Yanagisawa M, Kurihara H, Kimura S, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.
29. Dhaun N, Goddard J, Kohan DE, et al. (2008) Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension 52, 452-459.
30. Verma S, Buchanan MR & Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108, 2054-2059.
31. Vallance P, Leone A, Calver A, et al. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575.
32. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-Analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71-86.
33. US Department of Health and Human Services (2004) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC: US Department of Health and Human Services.
34. Edirisinghe I, Burton-Freeman B & Tissa KC (2008) Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond) 114, 331-337.
35. Siotia A, Buckland R, Judge HM, et al. (2006) Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention. Thromb Haemost 95, 997-1002.
36. Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S-2085S.
37. Feringa HH, Laskey DA, Dickson JE, et al. (2011) The effect of grape seed extract on cardiovascular risk markers: A metaanalysis of randomized controlled trials. J Am Diet Assoc 111, 1173-1181.
38. Gordon RD, Wolfe LK, Island DP, et al. (1966) A diurnal rhythm in plasma renin activity in man. J Clin Invest 45, 1587-1592.
39. Linsell CR, Lightman SL, Mullen PE, et al. (1985) Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 60, 1210-1215.
40. Snoep JD, Hovens MM, Pasha SM, et al. (2009) Timedependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension 54, 1136-1142.
41. Ralay RH, Diebolt M & Andriantsitohaina R (2004) Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: Involvement of nitric oxide. Br J Pharmacol 142, 671-678.
42. Feng Z, Wei RB, Hong Q, et al. (2010) Grape seed extract enhances eNOS expression and NO production through regulating calcium-mediated AKT phosphorylation in H2O2-Treated endothelium. Cell Biol Int 34, 1055-1061.
43. Khan NQ, Lees DM, Douthwaite JA, et al. (2002) Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (Lond) 103, Suppl. 48, 72S-75S.
44. Luscher TF & Barton M (2000) Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102, 2434-2440.
45. Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018-1025.
46. Tang WJ, Hu CP, Chen MF, et al. (2006) Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol 84, 163-171.
47. Xiao HB, Jun F, Lu XY, et al. (2009) Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level. Eur J Pharmacol 616, 213-222.